Sildenafil
Links shared publicly online about this topic
Sildenafil on #MDlinx
mdlinx.com — “Sildenafil on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 22, 2010 at 3:29 am By:
Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac d... http://bit.ly/cDDwV4 #urology
Nanotech for transdermal sildenafil
alphagalileo.org — “Nanotech for transdermal sildenafil” View full resource at alphagalileo.org
Most Recently Shared on July 26, 2011 at 7:56 pm By:
Nanotech for transdermal sildenafil: Sildenafil citrate, commonly known as Viagra, is… http://goo.gl/fb/SwF02
What Is Viagra? What Is Sildenafil Citrate?
medicalnewstoday.com — “Viagra is the brand name for Sildenafil citrate, and is used for treating erectile dysfunction and pulmonary arterial hypertension. Originally developed by scientists in Great Britain, it w” View full resource at medicalnewstoday.com
Most Recently Shared on August 17, 2011 at 10:05 pm By:
What Is Viagra? What Is Sildenafil Citrate? http://mnt.to/3Z2k #erectiledysfunction
Pediatrics Medical News about Sildenafil
mdlinx.com — “Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube” View full resource at mdlinx.com
Most Recently Shared on May 12, 2010 at 5:47 pm By:
Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube: BMJ ... http://bit.ly/dcNVY4 #peds
REVATIO (Sildenafil) drug information from MPR
empr.com — “REVATIO (Sildenafil) drug information for Pulmonary hypertension from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on February 23, 2011 at 5:06 am By:
MPR News: REVATIO: Warnings/Precautions: added PAH secondary to sickle cell anemia. Interactions: concomitant V... http://bit.ly/gDrjY8
Children With PAH May Benefit From Sildenafil
medicalnewstoday.com — “Sildenafil is currently approved for adult pulmonary arterial hypertension (PAH); however, new research presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2011 at 10:05 am By:
Children With PAH May Benefit From Sildenafil http://t.co/YLI8BfnH #pediatrics
Sildenafil Reduces Raynaud's Frequency In Patients With Systemic Sclerosis
medicalnewstoday.com — “Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sc” View full resource at medicalnewstoday.com
Most Recently Shared on March 9, 2011 at 9:05 am By:
Sildenafil Reduces Raynaud's Frequency In Patients With Systemic Sclerosis http://mnt.to/3S3H #arthritis
Nanotech for transdermal sildenafil - QualityPoint Technologies
qualitypointtech.net — “Sildenafil citrate, commonly known as Viagra, is currently the first choice drug for erectile dysfunction but despite its success oral delivery of the drug is hampered by numerous side effects, the long delay before it starts working and the short amount of time it lasts. Researchers in Egypt think they may have a solution via nanotechnology.” View full resource at qualitypointtech.net
Most Recently Shared on July 26, 2011 at 7:00 pm By:
Nanotech for transdermal sildenafil: Sildenafil citrate, commonly known as Viagra, is currently the first choice d... http://bit.ly/pnORpX
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis
physorg.com — “Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil ...” View full resource at physorg.com
Most Recently Shared on March 8, 2011 at 3:13 pm By:
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis http://tw.physorg.com/218800156
Sildenafil benefit small in patients with idiopathic pulmonary fibrosis
physorg.com — “Sildenafil failed to significantly increase exercise capacity, but did improve arterial oxygenation, shortness of breath and quality of life in patients with advanced idiopathic pulmonary fibrosis (IPF), in the first randomized trial of the medication for IPF. The study is published in the August 12, ...” View full resource at physorg.com
Most Recently Shared on September 22, 2010 at 1:19 pm By:
Sildenafil benefit small in patients with idiopathic pulmonary fibrosis http://tw.physorg.com/204365935
Roles of Sildenafil in Enhancing Drug Sensitivity in Cancer
cancerres.aacrjournals.org — “Roles of Sildenafil in Enhancing Drug Sensitivity in Cancer” View full resource at cancerres.aacrjournals.org
Most Recently Shared on June 1, 2011 at 11:32 pm By:
Sidenafil may enhance sensitivity of certain cancer types to chemotherapy http://bit.ly/jl3Zvy
REVATIO INJECTION (Sildenafil) drug information from MPR
empr.com — “REVATIO INJECTION (Sildenafil) drug information for Pulmonary hypertension from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on February 23, 2011 at 5:06 am By:
MPR News: REVATIO INJECTION: Monograph added. http://bit.ly/eVYEVA
Understanding The Effects Of Sildenafil Treatment On Erection Maintenance And Erection Hardness
medicalnewstoday.com — “UroToday.com - In our recent article published in the Journal of Sexual Medicine, we used statistical modeling to make the first-reported estimate of the extent to which treatment of erectile dys” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 1:54 pm By:
Understanding The Effects Of Sildenafil Treatment On Erection Maintenance And Erection Hardness: UroToday.com - ... http://mnt.to/f/3Mjc
NEJM -- A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
content.nejm.org — “Original Article from The New England Journal of Medicine -- A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis” View full resource at content.nejm.org
Most Recently Shared on May 18, 2010 at 9:36 pm By:
Sildenafil did not cause a sig. difference in improvement in walk distance tests in advanced IPF patients. http://bit.ly/acWwjl
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds
sciencedaily.com — “Researchers in Europe report that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects.” View full resource at sciencedaily.com
Most Recently Shared on March 8, 2011 at 2:51 pm By:
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds http://bit.ly/fgtz5G
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
MNT Erectile Dysfunc
The latest erectile dysfunction news published daily. Articles from research centers, universities and prestigious journals.
Advertisement

